Inspire Medical Systems Inc
NYSE:INSP

Watchlist Manager
Inspire Medical Systems Inc Logo
Inspire Medical Systems Inc
NYSE:INSP
Watchlist
Price: 187.58 USD -0.1% Market Closed
Market Cap: 5.6B USD
Have any thoughts about
Inspire Medical Systems Inc?
Write Note

Inspire Medical Systems Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inspire Medical Systems Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Inspire Medical Systems Inc
NYSE:INSP
Total Current Liabilities
$74.3m
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Total Current Liabilities
$857m
CAGR 3-Years
17%
CAGR 5-Years
23%
CAGR 10-Years
23%
Doximity Inc
NYSE:DOCS
Total Current Liabilities
$147.3m
CAGR 3-Years
13%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Total Current Liabilities
$961.5m
CAGR 3-Years
42%
CAGR 5-Years
33%
CAGR 10-Years
24%
Certara Inc
NASDAQ:CERT
Total Current Liabilities
$130m
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Total Current Liabilities
$123.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inspire Medical Systems Inc
Glance View

Market Cap
5.6B USD
Industry
Health Care

Inspire Medical Systems Inc. emerged as a beacon of innovation in the medical technology landscape, carving a niche within the realm of obstructive sleep apnea (OSA) treatment. Founded with a vision to redefine the approach to sleep disorders, the company developed a breakthrough solution—a device that stimulates the hypoglossal nerve to maintain an open airway during sleep. This technology, known as Inspire therapy, represents a significant departure from traditional treatments like the cumbersome and often uncomfortable Continuous Positive Airway Pressure (CPAP) machines. By addressing the root cause of airway obstruction, Inspire provides an effective, less intrusive alternative, enhancing the overall quality of life for patients who struggle with conventional methods. Inspire Medical Systems makes money by marketing its implantable device primarily through a network of sleep centers and hospitals. The company operates in a business model that combines device sales with a supportive service infrastructure, ensuring that both healthcare providers and patients are well-acquainted with its innovative therapy. The revenue stream is fueled not only by the initial sales of the device but also through ongoing follow-ups and software updates necessary for optimal device functionality. By positioning itself at the intersection of customer care and cutting-edge technology, Inspire captures significant value in the growing OSA market, all while reinforcing its reputation as a leader in innovative medical solutions.

INSP Intrinsic Value
83.5 USD
Overvaluation 55%
Intrinsic Value
Price

See Also

What is Inspire Medical Systems Inc's Total Current Liabilities?
Total Current Liabilities
74.3m USD

Based on the financial report for Sep 30, 2024, Inspire Medical Systems Inc's Total Current Liabilities amounts to 74.3m USD.

What is Inspire Medical Systems Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
42%

Over the last year, the Total Current Liabilities growth was 6%. The average annual Total Current Liabilities growth rates for Inspire Medical Systems Inc have been 30% over the past three years , 42% over the past five years .

Back to Top